|
Match
|
Document |
Document Title |
|
|
US20110218106 |
PLANT TREATMENT COMPOSITIONS PARTICULARLY EFFECTIVE IN THE CONTROL OF HETERANTHERAL LIMOSA ON RICE CROPS, AND METHODS FOR THEIR USE
Provided are improved agricultural processes for the improved cultivation of rice wherein the crops are treated to control undesired vegetative growth using a plant treatment composition... |
|
|
US20120282307 |
GASTRIC RETAINED GABAPENTIN DOSAGE FORM
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form. |
|
|
US20110319418 |
PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN
Disclosed are compounds, compositions and methods for treating pain, including inflammatory, visceral, and acute pain. Such compounds are represented by Formula (I) as follows: wherein A1, L1, D,... |
|
|
US20120141491 |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCERS AND PATHOGENIC INFECTIONS
The subject application provides small compounds that are able to increase/enhance autophagy in various cells. These compounds are useful in augmenting existing treatments of various cancers,... |
|
|
US20120015948 |
TABLET COMPOSITION
A water soluble effervescent disinfecting tablet comprises a chlorinated isocyanurate such as anhydrous sodium dichloroisocyanurate. The tablet also comprises an alkali metal bicarbonate such as... |
|
|
US20110217280 |
METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
Provided herein are methods for treating a subject suffering from a neuropsychiatric condition (e.g., schizophrenia). The methods include systemic administration of a pharmacological composition... |
|
|
US20080279959 |
ANTIMICROBIAL CREDIT CARDS, IDENTIFICATION CARDS, MEMBERSHIP CARDS AND IDENTIFICATION BADGES AND BADGE HOLDERS
A system, method and apparatus provices an antimicrobial card, badge holder or token made from an antimicrobial polymereric material. The antimicrobial polymereric material includes one or more... |
|
|
US20130101680 |
RADIOTHERAPY ENHANCER
The present invention relates to a method of treating pancreatic cancer in a subject in need thereof by administering an effective amount of a composition containing (A) tegafur and (B) gimeracil... |
|
|
US20070027140 |
N-heteroaryl indole carboxamides and analogues thereof, for use as glcokinase activators in the treatment of diabetes
This invention relates to compounds that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase... |
|
|
US20150166940 |
UNIVERSAL SURFACE DECONTAMINATION FORMULATION
Provided are decontamination compositions that include an ammonium compound, a ferric/ferrocyanide compound, a polyaminocarboxylic acid compound and a polycarboxylic compound. Depending on the... |
|
|
US20140024651 |
UNIVERSAL SURFACE DECONTAMINATION FORMULATION
Provided are decontamination compositions that include an ammonium compound, a ferric/ferrocyanide compound, a polyaminocarboxylic acid compound and a polycarboxylic compound. Depending on the... |
|
|
US20070197394 |
Hydrolysis resistant organomodified trisiloxane surfactants
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide... |
|
|
US20070191368 |
Inhibition of tissue damage to skin from radiation treatment therapy
A method of and composition for inhibiting the deleterious effects on mammalian skin tissue by radiation treatment therapy comprising administering to a patient in need thereof, in conjunction... |
|
|
US20140335174 |
DRY-COATED TABLET CONTAINING TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM
The present invention provides a dry-coated tablet comprising: an inner core containing, as active ingredients, (a) tegafur, (b) gimeracil, and (c) oteracil potassium; and an outer shell. |
|
|
US20050234030 |
Modulators of CRTH2, COX-2 and FAAH
Certain substituted indoles that are modulators of one or more or of CRTH2, COX-2 AND FAAH are described. The compounds are useful for treatment of pain and/or inflammation as well as other disorders. |
|
|
US20060246122 |
Solid transdermal therapeutic system with UV absorber
The UV-stable solid transdermal therapeutic system (TTS) with UV absorber for photosensitive active pharmaceutical ingredients has a backing layer (1), at least one active ingredient-containing... |
|
|
US20120178758 |
STYRYL-TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
The invention provides Styryl-Triazine derivatives, and further provides methods of using these compounds to modulate protein kinases and to treat protein kinase mediated diseases. |
|
|
US20100016313 |
INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF
Disclosed are modulators, i.e., activators and inhibitors, of Intestinal Alkaline Phosphatase (IAP). Also disclosed are methods for treating bacterial infections of the intestinal tract and... |
|
|
US20110136810 |
ANTITUMOR AGENT, KIT AND METHOD OF TREATING CANCER
Disclosed are an antitumor preparation comprising a combination of (1) a combination drug of tegafur/gimeracil/oteracil potassium, (2) at least one ingredient selected from the group consisting of... |
|
|
US20060287318 |
Method for treating glaucoma III B
Provided, among other things, is a method of decreasing intraocular pressure or improving ocular accommodation in an animal, including a human, comprising administering an intraocular pressure... |
|
|
US20090117406 |
CONCENTRATE FOR FILM PRESERVATION
The invention refers to a concentrate, in particular for the film preservation, a coating system as well as especial employment of a combination of active ingredients in the film preservation or... |
|
|
US20050197338 |
Substituted pyrazole urea compounds for the treatment of inflammation
Compounds of Formula I: wherein X1, X2, L1, A, R, L2, R1, R12, R12a, R13, R14 and R14a are as defined herein, are disclosed. |
|
|
US20130345222 |
IDENTIFICATION OF HUMAN T2R RECEPTORS THAT RESPOND TO BITTER COMPOUNDS THAT ELICIT THE BITTER TASTE IN COMPOSITIONS, AND THE USE THEREOF IN ASSAYS TO IDENTIFY COMPOUNDS THAT INHIBIT (BLOCK) BITTER TASTE IN COMPOSITIONS AND USE THEREOF
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the... |
|
|
US20080038303 |
Novel Solid Compositions for Disinfected Water
The present invention provides a method for the preparation of water-sanitizing solid, shaped compositions, said method comprising the steps of: mixing a halogenated 5,5-dimethylhydantoin compound... |
|
|
US20060142291 |
Use of formaldehyde and formaldehyde-releasing compounds in a composition for controlling mycobacteria
The invention relates to the use of a bactericide selected from formaldehyde and formaldehyde-releasing compounds in a composition for controlling mycobacteria, for example in a cooling lubricant. |
|
|
US20080119472 |
Solid Biocide Formulations
Abstract Biocidal compositions that contain biocidal components, such as an oxidant, and mixed with said components a combination of inorganic compounds capable of reducing the oxidative capacity... |
|
|
US20090274632 |
Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the... |
|
|
US20090181040 |
TRIAZINONE COMPOUNDS FOR TREATING DISEASES RESULTING FROM INFESTATION WITH PARASITIC PROTOZOANS
The present invention relates to the use of triazinones such as triazinediones and triazinetriones for triazinetriones for the preparation of compositions for treating animals, in particular... |
|
|
US20130078309 |
ORAL PARTICULATE ANTITUMOR PREPARATION
An oral particulate antitumor preparation, which allows safe intake of antitumor agents, handling of which could be in many cases dangerous due to their high pharmacological activity, and has a... |
|
|
US20070232586 |
Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
A compound having an inhibitory activity against cysteine protease, represented by formula (I): (wherein ring X is a heterocyclic group which may contain 1 to 4 hetero atoms selected from an... |
|
|
US20110136811 |
PROKINETICIN 1 RECEPTOR
The present invention relates to methods of monitoring the biological activity of the PK1 receptor. |
|
|
US20140329674 |
Honeybee Repellents and Uses Thereof
The present specification discloses honeybee repellents exhibiting repellent properties similar to 2-heptanone, compositions comprising such repellents, uses to repel a honeybee from a mammal,... |
|
|
US20070219199 |
Use of Sulfonanilides as Agricultural and Horticultural Fungicide
Compounds of the formula (I), wherein Z represents C—R7 or N, and R represents alkyl that may be optionally substituted, alkenyl, alkynyl, cycloalkyl or alkoxycarbonylamino, are useful as... |
|
|
US20120129862 |
PROKINETICIN 1 RECEPTOR ANTAGONISTS
The present invention relates to certain novel compounds of Formula (I): and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of... |
|
|
US20120108593 |
Extreme temperature aqueous decontamination composition
An extreme temperature decontamination composition such as a solution for destroying microorganisms, chemical warfare and bioterrorism agents is utilized that generally does not freeze at low... |
|
|
US20060264433 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
The present invention relates to compounds, which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as... |
|
|
US20130143886 |
METHODS FOR PRESERVING AND/OR INCREASING RENAL FUNCTION USING XANTHINE OXIDOREDUCTASE INHIBITORS
The present invention relates to methods of preserving or increasing renal function in a subject in need thereof by administering a therapeutically effective amount of at least one xanthine... |
|
|
US20080064653 |
USE OF ADENOSINE A2A MODULATORS TO TREAT SPINAL CORD INJURY
The present invention is a method for treatment or prevention of injury to nerve cells. The method can use at least one A2A receptor modulator to prevent injury to or enhance the healing of the... |
|
|
US20110144112 |
APOPTOSIS PROMOTERS
Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating... |
|
|
US20080015195 |
Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
Novel FBPase inhibitors of the formula I and X are useful in the treatment of diabetes and other conditions associated with elevated blood glucose. |
|
|
US20090325964 |
Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
The present teachings relate to piperazine metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulators having Formula I: wherein the constituent variables are as defined herein. The... |
|
|
US20110245324 |
ANTIMICROBIAL COMPOUNDS
The present invention relates to compounds that modulate the shikimate pathway and/or a pathway branching from the shikimate pathway in members of the Amoebida Order. In particular these compounds... |
|
|
US20150110864 |
NOVEL ANTITUMOR AGENT COMPRISING COMBINATION OF THREE AGENTS
A primary object of the present invention is to provide a novel combination therapy that exhibits a notable antitumor effect. As means for achieving the object, an antitumor agent comprising a... |
|
|
US20100323009 |
Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications
A solid composition in the form of a tablet that generates and releases a biocidal solution comprising at least chlorine dioxide with an enhanced weight percent yield is presented. The composition... |
|
|
US20100120773 |
METHOD OF TREATING DISORDERS MEDIATED BY THE FIBROBLAST GROWTH FACTOR RECEPTOR
The disclosure includes a method of treating a warm-blooded animal having a disorder mediated by the fibroblast growth factor receptor (FGFR), in particular 8p11 myelo-proliferative syndrome... |
|
|
US20050203082 |
Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents
A combination therapy comprising administration of a carbamoylating chemotherapeutic agent in conjunction with administration of a selective iNOS inhibitor compound is disclosed. Optionally,... |
|
|
US20100093736 |
AMINOALCOHOL AND BIOCIDE COMPOSITIONS FOR AQUEOUS BASED SYSTEMS
Biocidal compositions and their use in aqueous media, such as metalworking fluids, the compositions comprising a biocidal agent; and a non-biocidal primary amino alcohol compound of the formula... |
|
|
US20120316171 |
Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
Methods and compositions for the treatment and/or management of cancer are disclosed, which comprise the use of tryptophan hydroxylase inhibitors. |
|
|
US20140038966 |
TEGAFUR-CONTAINING COMPOSITION FOR SINGLE DAILY AND ALTERNATE-DAY DOSING
This invention provides an antitumor agent comprising a combination drug containing tegafur, gimeracil, and oteracil potassium, characterized by being repeatedly administered to a patient once a... |
|
|
US20130345050 |
Active Compound Combinations
The invention relates to active compound combinations, in particular a fungicidal and/or insecticidal composition, comprising Isotianil (3,4-dichloro-N-(2-cyanophenyl)-5-isothiazolecarboxamide)... |